Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
about
Regulation of ALK-1 signaling by the nuclear receptor LXRbetaCloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissuesSTRAP and Smad7 synergize in the inhibition of transforming growth factor beta signalingThe biological function of type I receptors of bone morphogenetic protein in boneAn Activin A/BMP2 Chimera, AB204, Displays Bone-Healing Properties Superior to Those of BMP2Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cellsPhysical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptorsSpecific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGF-beta family signals.Expression of bone morphogenetic protein 2, 4, and related components of the BMP signaling pathway in the mouse uterus during the estrous cycleA maternal Smad protein regulates early embryonic apoptosis in Xenopus laevis.Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-beta family ligands, receptors and Smad signal transducers.Identification of small molecule activators of BMP signalingIntegrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity.TGF-betas: their role in testicular function and Sertoli cell tight junction dynamics.The orphan nuclear receptor SHP is a positive regulator of osteoblastic bone formation.Determinants of specificity in TGF-beta signal transduction.The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in miceThe BMP signaling and in vivo bone formationFailure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2.CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cellsSignal transduction pathways that contribute to myeloid differentiation.Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiationAutoregulation of Xvent-2B; direct interaction and functional cooperation of Xvent-2 and Smad1.Structural basis for the functional difference between Smad2 and Smad3 in FAST-2 (forkhead activin signal transducer-2)-mediated transcription.Ventromorphins: A New Class of Small Molecule Activators of the Canonical BMP Signaling Pathway.Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptorsInteraction of Drosophila inhibitors of apoptosis with thick veins, a type I serine/threonine kinase receptor for decapentaplegic.Intracellular signaling of osteogenic protein-1 through Smad5 activation.Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase.Drosophila dSmad2 and Atr-I transmit activin/TGFbeta signals.The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors.Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.The effects of a single intravenous injection of novel activin A/BMP-2 (AB204) on toxicity and the respiratory and central nervous systems.Neural EGF-like protein 1 (NELL-1): Signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine.Identification of two Smad4 proteins in Xenopus. Their common and distinct properties.Smad8B, a Smad8 splice variant lacking the SSXS site that inhibits Smad8-mediated signalling.
P2860
Q24312839-BB89CA06-3F7C-4845-A392-B4B6DDD97638Q24337448-E7279CDD-9B38-44E6-A0E7-9A9520877EB6Q24554242-7669697D-64D5-44F1-8DCE-414232505830Q26752839-8A49F46A-A147-4E6B-9778-82B9E1FE44A3Q27682737-080331F3-0AB7-40BA-9B6F-EF54DA848F62Q28142906-7DCDA6D8-D462-48C1-BC66-2A029B88B919Q28282476-185FFA82-A71B-457C-83D1-A63EF7878B92Q28283345-7E986CFA-B0F8-4489-9EF2-0A70EF848A14Q29616540-5459D5D0-87B1-49A3-AE4A-CFC71A32C809Q33665042-FFF64A57-B9FB-4E33-9C36-D38A398671CDQ33899090-93B1252E-1CB7-4933-8284-25B5378643AAQ34302017-951DE631-6800-4647-8CE1-0D729D6DBED5Q34607080-8515A60F-A46B-46E9-A694-5C3EA24556C9Q34634563-4A39AB33-DF5F-48F1-8711-597322BB2420Q35035028-C1629ABC-A5B0-4053-8180-77D0E06800C6Q35130945-7EBCA869-4C40-4C34-AF85-8A279B44532DQ35156238-5641D21F-82AA-49EA-8B93-4EF05089129AQ35205890-6DADEB84-ECEB-428A-B719-FEB4654406B1Q36008239-555E3273-17E3-4047-A4E3-0A1B7A60B24CQ36242266-ECDBE94B-32EA-4FE6-B70E-A60E88619724Q36258971-658D31C2-A6FA-484D-B298-1F1E6FC21151Q36263679-381B9BF5-09D9-41EA-BDBE-0E19D8DD180AQ36795284-9E52BA08-A1C2-44E4-B0A7-6852327ED645Q36934968-E6094B30-C984-42D5-826D-0A8656633E97Q38294847-D3984ED3-3412-4839-A6F2-BD798CD85816Q38309778-786B97D2-8F9F-487E-86ED-7F11084991F7Q38695521-78BAD784-A43E-4755-896C-E194FB89C3DFQ40612692-85BDBA2E-ED8B-4CB2-B840-54B8254C5DB9Q40850821-13BA2436-7E44-4F3E-BA4C-9CAB5C699158Q40858627-B998032B-C300-4E3B-A154-ACCBFD853711Q41003486-C1F8FD18-E036-417D-AC22-A49E570BA08CQ41038879-CD93C5DD-A545-4AE1-863A-23FBE3BE92E6Q41785848-C426F6BD-4D2E-4C4C-A4B0-1C017208B8D8Q42601508-FC0E33F6-A501-4284-9A47-80142C133C05Q42638343-B3A2F80D-8B8F-4663-A71F-E209BFF80382Q44002044-F10CAE69-B927-401E-97F7-E236B4C68880Q46248136-FAB338B5-EEEF-46AE-8674-31D4C92E0220Q47141932-ADA3E680-C619-4819-8726-9C6218A02A21Q47971299-999F91A9-9BB4-4295-A26A-4E49E4C5DF3CQ52172810-94F3DFD0-8600-43B4-AF3B-71B1C9F9177F
P2860
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
description
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1997
@ast
im November 1997 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1997/11/25)
@sk
vědecký článek publikovaný v roce 1997
@cs
wetenschappelijk artikel (gepubliceerd op 1997/11/25)
@nl
наукова стаття, опублікована в листопаді 1997
@uk
name
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@ast
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@en
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@nl
type
label
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@ast
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@en
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@nl
prefLabel
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@ast
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@en
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@nl
P2093
P2860
P3181
P356
P1476
Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase
@en
P2093
P2860
P304
12938–12943
P3181
P356
10.1073/PNAS.94.24.12938
P407
P577
1997-11-25T00:00:00Z